The Relationship Between Controlling Risk Factors and Cerebral Haemodynamics in Lacunar Stroke
LACUNAR_CA
Understanding the Relationship Between Controlling Risk Factors and Cerebral Haemodynamic Changes in Lacunar Stroke, and Its Interaction With Ageing
2 other identifiers
observational
75
1 country
1
Brief Summary
The goal of this observational study is to look at differences in brain blood flow before and after management of risk factors such as high blood pressure and diabetes in patients with lacunar stroke. Participants will be asked to undergo a simple brain blood flow assessment at their initial appointment, whereby they will be asked to sit and stand twice. The patients will then be asked for a follow-up assessment 4 weeks after, identical to the first. This will allow us to look at any changes in brain blood flow from before management of risk factors and 4 weeks after management of risk factors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 19, 2024
CompletedFirst Posted
Study publicly available on registry
April 9, 2024
CompletedStudy Start
First participant enrolled
May 2, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2026
CompletedMarch 24, 2025
March 1, 2025
1.8 years
March 19, 2024
March 21, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Cerebral blood velocity measurements before and after management of uncontrolled risk-factors in those diagnosed with lacunar stroke syndromes.
Absolute values (cm/s) and percentage change (%) in cerebral blood velocity measurements before and after management of uncontrolled risk-factors in lacunar stroke patients.
From enrolment to the end of the follow-up measurements at 4 weeks.
Arterial blood pressure measurements before and after management of uncontrolled risk-factors in those diagnosed with lacunar stroke syndromes.
Absolute values (mmHg) and percentage change (%) in arterial blood pressure measurements before and after management of uncontrolled risk-factors in lacunar stroke patients.
From enrolment to the end of the follow-up measurements at 4 weeks.
Heart rate measurements before and after management of uncontrolled risk-factors in those diagnosed with lacunar stroke syndromes.
Absolute values (bpm) and percentage change (%) in heart rate measurements before and after management of uncontrolled risk-factors in lacunar stroke patients.
From enrolment to the end of the follow-up measurements at 4 weeks.
End-tidal carbon dioxide measurements before and after management of uncontrolled risk-factors in those diagnosed with lacunar stroke syndromes.
Absolute values (mmHg) and percentage change (%) in heart rate measurements before and after management of uncontrolled risk-factors in lacunar stroke patients.
From enrolment to the end of the follow-up measurements at 4 weeks.
Compare cerebral haemodynamics in lacunar stroke patients with older patients experiencing advanced chronic cerebrovascular disease with lacunar stroke syndromes, whose risk-factors are already managed.(CA).
Efficiency of regulatory mechanisms will be analysed through measuring cerebral autoregulation.
Data collected from enrolment to the end of the follow-up measurements at 4 weeks. Comparisons to other data and other studies to be done at analysis stage.
Compare cerebral haemodynamics in lacunar stroke patients with older patients experiencing advanced chronic cerebrovascular disease with lacunar stroke syndromes, whose risk-factors are already managed. (VMR).
Efficiency of regulatory mechanisms will be analysed through measuring vasomotor reactivity.
Data collected from enrolment to the end of the follow-up measurements at 4 weeks. Comparisons to other data and other studies to be done at analysis stage.
Compare cerebral haemodynamics in lacunar stroke patients with older patients experiencing advanced chronic cerebrovascular disease with lacunar stroke syndromes, whose risk-factors are already managed.(ARI).
Efficiency of regulatory mechanisms will be analysed through measuring the autoregulatory index.
Data collected from enrolment to the end of the follow-up measurements at 4 weeks. Comparisons to other data and other studies to be done at analysis stage.
Study Arms (1)
Lacunar Stroke Syndrome Patients
Patients who have been diagnosed with lacunar stroke syndrome. This is a non-intervention study so no intervention will be given. However, the investigators will observe the changes in cerebral haemodynamics of this group before and after they have been given medications to help control hypertension and/or diabetes which are common risk factors of lacunar stroke syndrome.
Interventions
TCD will be used to measure the cerebral blood flow in the middle and posterior cerebral arteries. This will be done at rest and during two sit-stand manoeuvres, whereby the participant will be asked to stand (from a seated position) and stay standing for 1 minute. The participant will then be given time to recover before repeating the manoeuvre. This will occur at the first visit and the follow-up visit 4 weeks after.
Eligibility Criteria
The participants will be recruited from Leicester Royal Infirmary TIA clinic or stroke ward.
You may qualify if:
- Adults aged between 18-120 years.
- Diagnosis of lacunar stroke syndrome.
- New diagnosis or known diagnosis of hypertension and/or diabetes.
You may not qualify if:
- Those who lack capacity can have a personal consultee consent to the study if they can still perform study requirements such as the sit-stand manoeuvre. Those who either cannot perform the manoeuvre or do not have a personal consultee to allow them to consent, are not able to take part.
- Those with poorly controlled medical comorbidities affecting cerebral haemodynamics. (eg., heart failure).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Leicesterlead
- British Heart Foundationcollaborator
- University Hospitals, Leicestercollaborator
Study Sites (1)
University Hospitals of Leicester NHS Trust
Leicester, Leicestershire, LE1 5WW, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 19, 2024
First Posted
April 9, 2024
Study Start
May 2, 2024
Primary Completion
March 1, 2026
Study Completion
March 1, 2026
Last Updated
March 24, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share
Individual patient data will not be shared, however once analysed and combined (statistically through mean averages etc), the results will be compiled into a report and submitted to a relevant journal, allowing researchers to view them.